The research into CMT2A, which has been performed relatively recently compared with research into other neurodegenerative diseases, has taught us that to improve our understanding of disease pathogenesis, the community must embrace the disease complexities and work with different models (Fig. 1). This evidence concerns the gene MFN2 and neurodegenerative disease.